Header Logo

LINA MERJANEH

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2023
264
1.710
 Why?
Hyperglycemia
2
2023
234
1.250
 Why?
Vomiting
1
2021
104
0.670
 Why?
Autoantibodies
1
2022
456
0.610
 Why?
Polycystic Ovary Syndrome
1
2019
74
0.570
 Why?
Disease Progression
3
2023
2191
0.530
 Why?
Diabetes Mellitus, Type 2
4
2024
1408
0.480
 Why?
Hypopituitarism
1
2015
18
0.470
 Why?
Diabetes Mellitus
1
2022
884
0.430
 Why?
Shock
1
2015
96
0.430
 Why?
Prediabetic State
1
2014
66
0.410
 Why?
Gastroenteritis
1
2015
316
0.390
 Why?
Insulin-Secreting Cells
1
2014
139
0.390
 Why?
Diabetes Mellitus, Type 1
3
2024
865
0.310
 Why?
Glucose Tolerance Test
2
2020
203
0.260
 Why?
Adolescent
8
2024
20814
0.240
 Why?
Acute Disease
2
2020
1153
0.230
 Why?
Young Adult
6
2024
10040
0.220
 Why?
Insulin
2
2022
1148
0.210
 Why?
Blood Glucose Self-Monitoring
1
2023
127
0.190
 Why?
Hypoglycemia
1
2022
180
0.170
 Why?
Diabetic Ketoacidosis
1
2022
163
0.160
 Why?
Menstruation Disturbances
1
2019
16
0.150
 Why?
Hyperandrogenism
1
2019
23
0.150
 Why?
Child
5
2024
26098
0.150
 Why?
Vascular Stiffness
1
2020
83
0.150
 Why?
Blood Glucose
1
2023
1102
0.150
 Why?
Glucose
1
2023
853
0.150
 Why?
Monitoring, Physiologic
1
2020
376
0.140
 Why?
Humans
11
2024
130931
0.140
 Why?
Cholesterol, LDL
1
2020
611
0.120
 Why?
Combined Modality Therapy
1
2019
1249
0.120
 Why?
Thyroid Hormones
1
2015
56
0.110
 Why?
Hydrocortisone
1
2015
223
0.110
 Why?
Cardiovascular Diseases
2
2024
2076
0.100
 Why?
Diagnosis, Differential
1
2019
1904
0.100
 Why?
Prevalence
1
2020
2681
0.100
 Why?
Glucose Intolerance
1
2014
83
0.100
 Why?
Male
5
2024
64823
0.100
 Why?
Statistics, Nonparametric
1
2014
429
0.100
 Why?
Reference Values
1
2014
689
0.100
 Why?
Hormone Replacement Therapy
1
2015
212
0.100
 Why?
Practice Guidelines as Topic
1
2019
1302
0.090
 Why?
Incidence
2
2024
3327
0.090
 Why?
Time Factors
1
2022
6275
0.090
 Why?
Age Factors
2
2020
2866
0.090
 Why?
Cross-Sectional Studies
2
2022
3799
0.080
 Why?
Sex Factors
1
2014
1344
0.080
 Why?
Adult
3
2023
31541
0.080
 Why?
Pediatrics
1
2019
1228
0.080
 Why?
Comorbidity
1
2014
1587
0.080
 Why?
Female
4
2024
70755
0.070
 Why?
Risk Assessment
1
2014
3675
0.060
 Why?
Prognosis
1
2014
4930
0.050
 Why?
Forced Expiratory Volume
1
2023
177
0.050
 Why?
Adrenal Cortex Hormones
1
2023
331
0.040
 Why?
Diabetic Angiopathies
1
2020
67
0.040
 Why?
Age of Onset
1
2020
631
0.040
 Why?
Insulin Resistance
1
2020
686
0.030
 Why?
Prospective Studies
1
2023
6443
0.020
 Why?
Anti-Bacterial Agents
1
2023
2558
0.020
 Why?
Cohort Studies
1
2020
5096
0.020
 Why?
Risk Factors
1
2024
10901
0.020
 Why?
Retrospective Studies
1
2023
17485
0.010
 Why?
United States
1
2020
11718
0.010
 Why?
MERJANEH's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_